Nierenzellkarzinome im Kindesalter

Standard

Nierenzellkarzinome im Kindesalter. / Weisbach, L; Aziz, A; Fisch, M; Riechardt, S.

In: UROLOGE, Vol. 56, No. 7, 07.2017, p. 900-904.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Weisbach, L, Aziz, A, Fisch, M & Riechardt, S 2017, 'Nierenzellkarzinome im Kindesalter', UROLOGE, vol. 56, no. 7, pp. 900-904. https://doi.org/10.1007/s00120-017-0420-6

APA

Weisbach, L., Aziz, A., Fisch, M., & Riechardt, S. (2017). Nierenzellkarzinome im Kindesalter. UROLOGE, 56(7), 900-904. https://doi.org/10.1007/s00120-017-0420-6

Vancouver

Weisbach L, Aziz A, Fisch M, Riechardt S. Nierenzellkarzinome im Kindesalter. UROLOGE. 2017 Jul;56(7):900-904. https://doi.org/10.1007/s00120-017-0420-6

Bibtex

@article{7f78c843bbaf444cb24a4b0c8f3dd195,
title = "Nierenzellkarzinome im Kindesalter",
abstract = "BACKGROUND: Renal cell carcinoma is a rare childhood disease. However, it should be considered in the differential diagnosis in the detection of a renal mass.OBJECTIVES: Incidence and mortality of renal cell carcinomas in childhood. Presentation of clinical symptoms, diagnostics, histology, therapy and course of the disease.PATIENTS AND METHODS: Evaluation of our own prospective data of a small patient population of 8 patients, as well as discussion of the current literature on this tumor entity.RESULTS: The average follow-up period was 27 months. Preoperative staging studies showed no metastases. The histologically primary predominant subtype was papillary renal cell carcinoma. Tumor stage and lymph node status were the most important prognostic factors in our study.CONCLUSIONS: Renal cell carcinoma in childhood is a rare disease whose treatment is challenging and should be performed in an interdisciplinary team. Typical clinical symptoms, as in adults, are absent. The partial nephrectomy should be, if practicable, the surgical treatment of choice. The most important risk factors for survival are tumor stage and lymph node status. Data on adjuvant target therapy for metastatic disease in childhood are lacking. Further prospective, multicenter studies are necessary to generate more information on the biology and course of this disease and to obtain adjuvant treatment options in locally advanced disease.",
keywords = "English Abstract, Journal Article",
author = "L Weisbach and A Aziz and M Fisch and S Riechardt",
year = "2017",
month = jul,
doi = "10.1007/s00120-017-0420-6",
language = "Deutsch",
volume = "56",
pages = "900--904",
journal = "UROLOGE",
issn = "0340-2592",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - Nierenzellkarzinome im Kindesalter

AU - Weisbach, L

AU - Aziz, A

AU - Fisch, M

AU - Riechardt, S

PY - 2017/7

Y1 - 2017/7

N2 - BACKGROUND: Renal cell carcinoma is a rare childhood disease. However, it should be considered in the differential diagnosis in the detection of a renal mass.OBJECTIVES: Incidence and mortality of renal cell carcinomas in childhood. Presentation of clinical symptoms, diagnostics, histology, therapy and course of the disease.PATIENTS AND METHODS: Evaluation of our own prospective data of a small patient population of 8 patients, as well as discussion of the current literature on this tumor entity.RESULTS: The average follow-up period was 27 months. Preoperative staging studies showed no metastases. The histologically primary predominant subtype was papillary renal cell carcinoma. Tumor stage and lymph node status were the most important prognostic factors in our study.CONCLUSIONS: Renal cell carcinoma in childhood is a rare disease whose treatment is challenging and should be performed in an interdisciplinary team. Typical clinical symptoms, as in adults, are absent. The partial nephrectomy should be, if practicable, the surgical treatment of choice. The most important risk factors for survival are tumor stage and lymph node status. Data on adjuvant target therapy for metastatic disease in childhood are lacking. Further prospective, multicenter studies are necessary to generate more information on the biology and course of this disease and to obtain adjuvant treatment options in locally advanced disease.

AB - BACKGROUND: Renal cell carcinoma is a rare childhood disease. However, it should be considered in the differential diagnosis in the detection of a renal mass.OBJECTIVES: Incidence and mortality of renal cell carcinomas in childhood. Presentation of clinical symptoms, diagnostics, histology, therapy and course of the disease.PATIENTS AND METHODS: Evaluation of our own prospective data of a small patient population of 8 patients, as well as discussion of the current literature on this tumor entity.RESULTS: The average follow-up period was 27 months. Preoperative staging studies showed no metastases. The histologically primary predominant subtype was papillary renal cell carcinoma. Tumor stage and lymph node status were the most important prognostic factors in our study.CONCLUSIONS: Renal cell carcinoma in childhood is a rare disease whose treatment is challenging and should be performed in an interdisciplinary team. Typical clinical symptoms, as in adults, are absent. The partial nephrectomy should be, if practicable, the surgical treatment of choice. The most important risk factors for survival are tumor stage and lymph node status. Data on adjuvant target therapy for metastatic disease in childhood are lacking. Further prospective, multicenter studies are necessary to generate more information on the biology and course of this disease and to obtain adjuvant treatment options in locally advanced disease.

KW - English Abstract

KW - Journal Article

U2 - 10.1007/s00120-017-0420-6

DO - 10.1007/s00120-017-0420-6

M3 - SCORING: Zeitschriftenaufsatz

C2 - 28600591

VL - 56

SP - 900

EP - 904

JO - UROLOGE

JF - UROLOGE

SN - 0340-2592

IS - 7

ER -